RANDAL ANTLE: Open Payments
NPI 1124262423 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 23 payments from 10 companies in 2025. Trend: 2023 $599 · 2024 $702 · 2025 $726
Food & beverage: $718Education: $8
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $199 |
| Organon LLC | 4 | $198 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Lilly USA, LLC | 2 | $56 |
| PFIZER INC. | 2 | $50 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $36 |
| LEO Pharma Inc. | 1 | $31 |
| Galderma Laboratories, L.P. | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
Products named: DUPIXENT, VTAMA, Rhapsido, CIBINQO, Zoryve, SKYRIZI, ANZUPGO, EBGLYSS.
Industry payments across GA — which companies pay providers there.
